Cloud Pharmaceuticals Announces 2015 Partnering Sessions and Presentation Schedule
RESEARCH TRIANGLE PARK, N.C., Jan. 27, 2015 /PRNewswire/ -- For Cloud Pharmaceuticals, Inc., a therapeutics company focused on cloud-based drug design and development, partnering is an integral part of its business strategy. The company's mission is to design new drugs and identify early stage, preclinical, IND, and Phase 1 and 2 partners to further their development. The company also partners with funds to enhance its portfolio investments. To support this business model, Cloud Pharmaceuticals will be participating in the following industry and investor events:
- Biocom's Global Life Science Partnering Conference
February 25-26, 2015
La Jolla, Calif.
Meet Cloud Pharmaceutical CEO Ed Addison at this exclusive global partnering and networking forum that features case study presentations, panel discussions, individual company presentations, one-on-one meetings, and numerous networking opportunities.
- 2015 CED Life Science Conference
March 3-4, 2015
Raleigh, N.C.
Meet with Don Van Dyke and Ed Addison from Cloud Pharmaceuticals at this event and explore the many new innovative models emerging in an evolving life sciences landscape. This conference will feature insights from world-class life science entrepreneurs, analysis of new models in life science innovation, can't-miss pitches from leading entrepreneurial companies, plus hundreds of VC, angel, and corporate investors looking for the next big idea.
- BIO-Europe Spring
March 9-11, 2015
Paris
Identify, meet, and initiate partnerships with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative start-ups. Join Ed Addison as he discusses how Cloud Pharmaceuticals is speeding the design and development of new drugs and drug candidates by implementing innovative cloud computing technology and managing the development of multiple assets through an extensive network of partners.
- Advances in Drug Delivery
March 12, 2015
Cambridge, Mass.
Discuss solutions for drug development challenges facing every R&D team today. Hear Shahar Keinan, Cloud Pharmaceuticals' CSO as she presents: Data Driven Drug Design: In Silico Optimization of BBB Permeability and Toxicity for Better Drugs (3:15 pm to 3:45 pm)
- Bio-IT World Conference & Expo
April 21-23, 2015
Boston
Share information and discuss enabling technologies that are driving biomedical research and the drug development process. Join Cloud Pharmaceuticals CEO Ed Addison on Wednesday, April 22, 2015 at 4:30 pm for his session titled: Using Cloud Computing to Improve the Accuracy and Probability of Success of Drug Discovery
- Bio-Trinity
May 11-13, 2015
London
Meet with Cloud Pharmaceuticals CEO Ed Addison at this biopartnering and investment conference focused on bringing together R&D companies, big pharma, and medtech corporates with biomedical investors.
- 2015 BIO International Convention
June 15-18, 2015
Philadelphia
Join Cloud Pharmaceuticals at this event that is attended by high-level executives and influential decision makers who come to BIO to discover new players in the industry, form partnerships, and evaluate emerging technologies.
To learn more please visit www.cloudpharmaceuticals.com. To meet with a representative of Cloud Pharmaceuticals during one of these events, please e-mail us at [email protected].
About Cloud Pharmaceuticals, Inc.
Cloud Pharmaceuticals is a leader in the computational design of new drugs and subsequent rapid, information-driven drug development. We accelerate the drug discovery and design process in a way that delivers tangible results and true value for our partners. For information visit www.cloudpharmaceuticals.com.
SOURCE Cloud Pharmaceuticals, Inc.
Share this article